Skip to content
Learning that drives better investment decisions

A Tale of Two Health Companies: Bumrungrad vs ZMC

The healthcare sector has long been one of the most consistently solid performers around the globe. However, that certainly doesn’t mean that every health and medical investment is created equal – and that’s particularly true on a global scale. Take for instance Bumrungrad Hospital (BH TB) in Bangkok, Thailand and Zhejiang Medicine Co. (600216 CH) in China – two companies in the sector that are on very different trajectories. For an in-depth breakdown on what makes has led these companies on such different paths, check out the video below:



What are your thoughts on the Health Care Sector? What do you think about Bumrungrad and ZMC? I would love to hear your thoughts! Any comments or question you might have, I would like to know.  Is anything unclear? Please let me know in a comment below. 


DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.

Originally published on August 20, 2015 at: